Stephen Kanes

Filings by Stephen Kanes span 2 companies, the busiest being Centessa Pharmaceuticals plc and Sage Therapeutics, Inc. We count 4 filings; the first trade dates from 15 June 2021 and the latest from 24 June 2026.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Most recently, on 24 June 2026, the filings show a transaction in Centessa Pharmaceuticals plc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.